TDAM USA’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $20.9M | Sell |
154,339
-1,024
| -0.7% | -$121K | 1.3% | 16 |
|
|
2021
Q3 | $16.8M | Sell |
155,363
-1,973
| -1% | -$225K | 1.1% | 23 |
|
|
2021
Q2 | $18.3M | Sell |
157,336
-5,150
| -3% | -$580K | 1.13% | 19 |
|
|
2021
Q1 | $17.6M | Buy |
162,486
+340
| +0.2% | +$36.4K | 1.07% | 21 |
|
|
2020
Q4 | $17.4M | Sell |
162,146
-18,758
| -10% | -$1.8M | 1.09% | 24 |
|
|
2020
Q3 | $15.8M | Sell |
180,904
-7,629
| -4% | -$718K | 1.09% | 22 |
|
|
2020
Q2 | $18.2M | Sell |
188,533
-11,710
| -6% | -$1.03M | 1.32% | 15 |
|
|
2020
Q1 | $15.3M | Buy |
200,243
+11,449
| +6% | +$975K | 1.28% | 16 |
|
|
2019
Q4 | $16.7M | Sell |
188,794
-735
| -0.4% | -$61K | 1.08% | 24 |
|
|
2019
Q3 | $14.4M | Sell |
189,529
-17,457
| -8% | -$1.2M | 1.02% | 26 |
|
|
2019
Q2 | $15.1M | Sell |
206,986
-5,368
| -3% | -$422K | 1.05% | 26 |
|
|
2019
Q1 | $17.1M | Sell |
212,354
-24,899
| -10% | -$2.04M | 1.22% | 22 |
|
|
2018
Q4 | $21.9M | Sell |
237,253
-9,694
| -4% | -$852K | 1.59% | 11 |
|
|
2018
Q3 | $24.1M | Sell |
246,947
-3,739
| -1% | -$355K | 1.46% | 11 |
|
|
2018
Q2 | $23.2M | Sell |
250,686
-107,442
| -30% | -$10.5M | 1.47% | 12 |
|
|
2018
Q1 | $33.9M | Sell |
358,128
-55,936
| -14% | -$6.14M | 2.06% | 5 |
|
|
2017
Q4 | $40M | Sell |
414,064
-6,659
| -2% | -$628K | 2.29% | 4 |
|
|
2017
Q3 | $37.4M | Sell |
420,723
-41,306
| -9% | -$3.14M | 2.2% | 4 |
|
|
2017
Q2 | $33.5M | Sell |
462,029
-19,203
| -4% | -$1.29M | 1.72% | 7 |
|
|
2017
Q1 | $31.4M | Buy |
481,232
+5,885
| +1% | +$370K | 1.59% | 11 |
|
|
2016
Q4 | $29.8M | Sell |
475,347
-37,701
| -7% | -$2.3M | 1.56% | 10 |
|
|
2016
Q3 | $32.4M | Sell |
513,048
-4,045
| -0.8% | -$262K | 1.6% | 8 |
|
|
2016
Q2 | $32M | Sell |
517,093
-6,379
| -1% | -$389K | 1.57% | 9 |
|
|
2016
Q1 | $29.9M | Buy |
523,472
+12,876
| +3% | +$718K | 1.46% | 12 |
|
|
2015
Q4 | $30.2M | Buy |
510,596
+38,202
| +8% | +$2.2M | 1.47% | 12 |
|
|
2015
Q3 | $25.7M | Buy |
472,394
+81,708
| +21% | +$5.32M | 1.31% | 17 |
|
|
2015
Q2 | $26.3M | Buy |
390,686
+1,524
| +0.4% | +$99.5K | 1.19% | 18 |
|
|
2015
Q1 | $22.8M | Buy |
389,162
+80,737
| +26% | +$4.88M | 0.93% | 33 |
|
|
2014
Q4 | $20.2M | Sell |
308,425
-905
| -0.3% | -$57.1K | 0.85% | 43 |
|
|
2014
Q3 | $17.9M | Sell |
309,330
-4,090
| -1% | -$227K | 0.77% | 46 |
|
|
2014
Q2 | $17.7M | Sell |
313,420
-2,731
| -0.9% | -$143K | 0.75% | 46 |
|
|
2014
Q1 | $16.3M | Buy |
316,151
+95,453
| +43% | +$4.82M | 0.71% | 51 |
|
|
2013
Q4 | $11.7M | Buy |
220,698
+130,639
| +145% | +$6.42M | 0.5% | 67 |
|
|
2013
Q3 | $4.03M | Sell |
90,059
-87,139
| -49% | -$3.86M | 0.19% | 107 |
|
|
2013
Q2 | $7.56M | Buy |
+177,198
| New | +$7.75M | 0.35% | 80 |
|
Other funds holding ABBV
TDAM USA's ABBV Position: Q4 2021 in Review
TDAM USA reduced its AbbVie (ABBV) stake by 0.66% in Q4 2021, selling an estimated $121K and leaving 154,339 shares worth $20.9M. The position accounts for 1.3% of the portfolio, ranked #16.
TDAM USA first reported a position in ABBV in Q2 2013 and has held it in 35 quarters since. The position peaked at $40M in Q4 2017. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.
- TDAM USA held 154,339 shares of AbbVie worth $20.9M as of Q4 2021.
- TDAM USA sold 1,024 AbbVie shares in Q4 2021, an estimated $121K.
- AbbVie made up 1.3% of TDAM USA's portfolio in Q4 2021, its #16 holding.
- TDAM USA first reported a position in AbbVie in Q2 2013 and has held it in 35 quarters since.
- TDAM USA's AbbVie position peaked at $40M in Q4 2017.
- 2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.
Based on TDAM USA's 13F filing for Q4 2021, filed 10 Feb 2022.